School of Health Sciences
Brook Building, BB230
After studying at Oxford Medical School, Ami trained as a junior doctor in several hospitals across the NHS. With a Masters in Public Health from Harvard University and a DPhil from Oxford, his expertise lies in epidemiology and public health, particularly relating to cardiovascular disease.
Ami has published on diverse topics from global health and medical education to vascular disease and patent law, and has acted as an advisor to the Cardiovascular Diseases Division at the World Health Organization. He is a Medical Advisor for the Health Impact Fund (www.healthimpactfund.com), a novel proposal to incentivize the development and delivery of new medicines by paying drug companies for the health impact of their medicines. Ami has been Clinical Lecturer in Cardiovascular Medicine at the University of Birmingham since March 2011, spending his time between cardiology, research and teaching. He joined UCLAN as a Senior Research Fellow in 2014 as a co-applicant on the REWARD project, funded by the European Research Council.
2011 DPhil (Oxon)
2007 MRCP (London)
2005 MPH (Harvard)
2002 MBBCh (Oxon)
1999 MA Hons (Oxon)
Ng M…….Banerjee A…….Lopez AD, Murray CJ, Gakidou E. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014 May 28. [Epub ahead of print].
Wang H……..Banerjee A……….Zhu S, Lopez AD, Murray CJ. Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014 May 2 [Epub ahead of print]
Banerjee A, Pogge T, Hollis A. The health impact fund. Lancet. 2010;375:1693
Bhala N, Taggar JS, Rajasekhar P, Banerjee A. Anticipating and managing bleeding complications in patients with coronary stents who are receiving dual antiplatelet treatment.BMJ. 2011; 343:d4264.